HK1138200A1 - 用於預防和/或治療脂肪肝或非酒精性脂肪性肝炎的藥物 - Google Patents

用於預防和/或治療脂肪肝或非酒精性脂肪性肝炎的藥物

Info

Publication number
HK1138200A1
HK1138200A1 HK10104346.1A HK10104346A HK1138200A1 HK 1138200 A1 HK1138200 A1 HK 1138200A1 HK 10104346 A HK10104346 A HK 10104346A HK 1138200 A1 HK1138200 A1 HK 1138200A1
Authority
HK
Hong Kong
Prior art keywords
fatty liver
drug
preventing
treating
nonalcoholic
Prior art date
Application number
HK10104346.1A
Other languages
English (en)
Inventor
Yuji Yoshikawa
Megumi Yamamoto
Naoto Ishibashi
Mami Seki
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of HK1138200A1 publication Critical patent/HK1138200A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10104346.1A 2007-03-30 2010-05-03 用於預防和/或治療脂肪肝或非酒精性脂肪性肝炎的藥物 HK1138200A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007090114 2007-03-30
PCT/JP2008/000760 WO2008126363A1 (ja) 2007-03-30 2008-03-27 脂肪肝又は非アルコール性脂肪性肝炎の予防及び／又は治療のための医薬

Publications (1)

Publication Number Publication Date
HK1138200A1 true HK1138200A1 (zh) 2010-08-20

Family

ID=39863523

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104346.1A HK1138200A1 (zh) 2007-03-30 2010-05-03 用於預防和/或治療脂肪肝或非酒精性脂肪性肝炎的藥物

Country Status (8)

Country Link
US (2) US20100120914A1 (zh)
EP (1) EP2143430B1 (zh)
JP (2) JP5341749B2 (zh)
KR (1) KR101461252B1 (zh)
CN (1) CN101652134B (zh)
ES (1) ES2555782T3 (zh)
HK (1) HK1138200A1 (zh)
WO (1) WO2008126363A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5725491B2 (ja) * 2010-04-14 2015-05-27 国立大学法人鳥取大学 レチノイン酸受容体リガンドによるインスリン抵抗性改善作用
JP5304939B1 (ja) * 2012-05-31 2013-10-02 大日本印刷株式会社 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法
GB201301626D0 (en) * 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
EP2808031A1 (en) * 2013-05-30 2014-12-03 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Sex hormone-binding globulin for use as a medicament

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140949A (en) * 1980-04-07 1981-11-04 Eisai Co Ltd 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenic acid
JPS57106638A (en) * 1980-12-24 1982-07-02 Eisai Co Ltd Conjugated polyprenylcarboxylic acid and its derivative
JPS6332058A (ja) 1986-07-22 1988-02-10 株式会社　梅彦 石材の床張り方法
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
JPH09194362A (ja) * 1996-01-19 1997-07-29 Bizen Kasei Kk ドコサヘキサエン酸及びエイコサペンタエン酸含有リン脂質を含む組成物
ES2343166T3 (es) * 2000-04-24 2010-07-26 Kowa Company, Ltd. Activadores para el receptor activado por proliferador de peroxisoma.
JP2002104965A (ja) * 2000-09-27 2002-04-10 Kanegafuchi Chem Ind Co Ltd 脂肪肝予防・改善機能を有する組成物
KR20050024274A (ko) * 2002-05-17 2005-03-10 니켄 가가쿠 가부시키가이샤 ＴＧＦ-α 발현 억제제
JP2004290821A (ja) 2003-03-27 2004-10-21 Aichi Electric Co Ltd 混合装置
JP4886506B2 (ja) * 2004-02-25 2012-02-29 国立大学法人 東京大学 転写因子ｋｌｆ５の活性化抑制作用を有する医薬
JP2006232711A (ja) * 2005-02-24 2006-09-07 Tohoku Univ 血中中性脂肪低下作用および肝臓中性脂肪合成抑制作用および血小板凝集抑制作用を有する油脂
JP5099808B2 (ja) * 2006-05-29 2012-12-19 独立行政法人農業・食品産業技術総合研究機構 脂質代謝改善用組成物
JP2008150307A (ja) * 2006-12-15 2008-07-03 Kenko Tsusho Kk 体脂肪の蓄積に起因する疾患の治療剤

Also Published As

Publication number Publication date
CN101652134A (zh) 2010-02-17
EP2143430A4 (en) 2010-12-29
US20120259015A1 (en) 2012-10-11
KR101461252B1 (ko) 2014-11-12
CN101652134B (zh) 2015-07-15
KR20100015986A (ko) 2010-02-12
WO2008126363A1 (ja) 2008-10-23
US20100120914A1 (en) 2010-05-13
US8673976B2 (en) 2014-03-18
EP2143430B1 (en) 2015-09-23
ES2555782T3 (es) 2016-01-08
EP2143430A1 (en) 2010-01-13
JP2013216679A (ja) 2013-10-24
JP5341749B2 (ja) 2013-11-13
JPWO2008126363A1 (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
HK1215533A1 (zh) 治療脂肪肝疾病的方法
HK1212598A1 (zh) 用於預防口腔疾病的組合物及方法
CA2645871A1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OXALATE-ASSOCIATED DISEASE
GB0621452D0 (en) Therapy for liver disease
EP1987141A4 (en) COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-CONDITIONAL DISEASES
EP1872724A4 (en) ULTRASONOGRAPH AND METHOD OF CREATING ULTRASONOGRAM
PL2578081T3 (pl) Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
ZA201102035B (en) Methods and formulations for treating chronic liver disease
EP2170311A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES
EP2549997A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NON ALCOHOLIC HEALING STEATOSIS AND METHOD FOR THE PREVENTION OR TREATMENT OF NON ALCOHOLIC HEALING STEATOSIS USING THE SAME
EP1974750A4 (en) PREVENTIVE OR THERAPEUTIC PROCEDURES AND METHODS FOR IMMUNOLOGICAL DISEASES
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
EP1971354A4 (en) LIQUIRITIGENIN-BASED COMPOSITION FOR THE PREVENTION AND TREATMENT OF HEPATIC DISEASES
EP2069391A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING EYE DRYING
EP2091545A4 (en) COMPOSITION COMPRISING A COMBINED HERBS EXTRACT USED TO PREVENT AND TREAT DISEASES OF HEPATITIS
PL2234631T3 (pl) Związki i metody stosowane w terapii choroby naczyniowej
EP2231148A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE
IL195771A0 (en) Methods and immune modulatory nucleic acid compositions for preventing and treating disease
HK1129596A1 (zh) 治療疾病的方法和配方
HK1138200A1 (zh) 用於預防和/或治療脂肪肝或非酒精性脂肪性肝炎的藥物
EP2199381A4 (en) SYSTEM FOR FORMATION AND MAINTENANCE OF BIOLOGICAL TISSUE
EP1970078A4 (en) COMPOSITION FOR INHIBITING A TARGET GENE IN AN EYEBORN AND REMEDY FOR ACAPIC DISEASE
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
GB0603901D0 (en) Cancer imaging and treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200327